Could Burr’s New User Fee Bill Lead to Timely Passage of Legislation?

Could Burr’s New User Fee Bill Lead to Timely Passage of Legislation?

With just days left before a deadline to send layoff notices to thousands of Food and Drug Administration (FDA) staff, legislation to reauthorize prescription drug user fees has not yet been passed. Will a "clean" bill offered by Sen. Richard Burr (R-N.C.) help?...

 

July 18, 2022 5:02 PM
Read More +

FDA Proposes Increased Consumer Access to Nonprescription Drugs, with Conditions

FDA Proposes Increased Consumer Access to Nonprescription Drugs, with Conditions

Providing a new pathway for drug companies and consumers that would enable additional drugs to become available without a prescription is the goal of a recent proposed rule from the FDA...

July 11, 2022 4:26 PM
Read More +

OPDP: Risk, Efficacy Claims for Cholesterol Drug in Doctor Promotion Are False/Misleading

OPDP: Risk, Efficacy Claims for Cholesterol Drug in Doctor Promotion Are False/Misleading

False or misleading claims and representations in a professional promotion about the efficacy and risks of a prescription drug for high cholesterol are cited in a June 2 Untitled Letter from OPDP to Althera Pharmaceuticals LLC...

 

June 27, 2022 1:52 PM
Read More +

HHS Formally Withdraws SUNSET Final Rule

HHS Formally Withdraws SUNSET Final Rule

HHS has formally withdrawn a Trump administration rule -- the “Securing Updated and Necessary Statutory Evaluations Timely” (SUNSET) final rule -- that threatened to cause many HHS regulations to expire...

June 20, 2022 1:25 PM
Read More +

Recent Posts

OPDP Reorg, Outreach Efforts Designed to Improve Relationship with Industry

06, 13, 2022

Read more

OPDP to Study Risk/Benefit Tradeoff Decisions Made by Consumers, Physicians

05, 31, 2022

Read more

Only 6 Percent of Novel Drug Approvals in 2021 Involved Advisory Committee Meetings

05, 23, 2022

Read more

Upcoming Event

{title}

{body}

Read More +

About Us

CHC

CHC

The Coalition for Healthcare Communication is an organization that promotes the free exchange of scientific and medical information. It is essential that healthcare professionals and the general public receive truthful, accurate information regarding pharmaceuticals, medical products and devices, and patient care.

In addition to white papers and other documents published by the Coalition, you can also find relevant information on current healthcare and health economics issues, as well as policy positions published by government agencies and other professional organizations.